Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115384) titled 'Study on the Efficacy and Safety of Crisogabalin in Fibromyalgia Patients' on Dec. 25, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Wenzhou Medical University
Condition:
Fibromyalgia
Intervention:
pregabalin group:pregabalin
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-12-31
Target Sample Size: pregabalin group:55;crisogabalin group:55;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301229
Disclaimer: Curated by HT Syndication....